Skip to content

Does Vitamin K2 MK7 Lower Blood Pressure? Unpacking the Cardiovascular Benefits

4 min read

Cardiovascular disease remains the leading cause of death worldwide. Emerging research suggests a connection between the fat-soluble nutrient vitamin K2 MK7 and cardiovascular health, leading many to ask: Does vitamin K2 MK7 lower blood pressure? Evidence indicates it may play a supportive role by improving arterial elasticity.

Quick Summary

Vitamin K2 MK7 helps prevent arterial calcification by activating proteins that direct calcium away from blood vessels. Studies show potential for reducing arterial stiffness and blood pressure, particularly in postmenopausal women with high arterial stiffness.

Key Points

  • Arterial Stiffness: Vitamin K2 MK7 helps prevent arterial stiffness, a major factor in high blood pressure, by preventing calcium buildup in artery walls.

  • Matrix Gla Protein Activation: MK7 activates Matrix Gla Protein (MGP), which is a key inhibitor of vascular calcification.

  • Positive Clinical Findings: Studies have shown that MK7 supplementation can improve arterial elasticity and, in some cases, lower blood pressure in specific populations, such as postmenopausal women and kidney transplant recipients.

  • Synergy with Vitamin D: The combination of vitamins D3 and K2 ensures that calcium is properly utilized for bone health and kept out of arteries.

  • Dietary Sources: Natto is a primary dietary source of MK7, alongside some other fermented foods and animal products.

  • Safety Precautions: Individuals on blood-thinning medications like warfarin should consult a doctor before taking MK7 supplements due to potential interactions.

In This Article

The Mechanism Behind Vitamin K2 MK7's Cardiovascular Impact

Vitamin K is a fat-soluble vitamin known for its role in blood clotting. However, its specific form, vitamin K2 (menaquinone), has a distinct function related to calcium metabolism outside of the liver, which is especially important for cardiovascular health. The subtype MK7, found in fermented foods like natto, is particularly effective due to its longer half-life in the body compared to other forms. Its primary mechanism involves activating a key protein called Matrix Gla Protein (MGP).

Activating Matrix Gla Protein (MGP)

Arterial stiffness, a major contributor to high blood pressure, is often caused by the accumulation of calcium deposits in the arterial walls. To combat this, the body uses MGP, a potent inhibitor of vascular calcification. For MGP to function correctly, it must be activated by vitamin K2. A deficiency in vitamin K2 leads to high levels of inactive MGP (dp-ucMGP), which correlates with increased arterial stiffness and a higher risk of cardiovascular events.

Reducing Arterial Stiffness

By ensuring the activation of MGP, vitamin K2 MK7 helps maintain the elasticity and flexibility of blood vessels. This mechanism directly addresses one of the root causes of hypertension, as more flexible arteries can better regulate blood flow and pressure. This protective effect is a key reason why researchers are investigating how MK7 impacts blood pressure, with several studies pointing toward a significant benefit, especially in at-risk groups.

Clinical Evidence on Blood Pressure and MK-7

Numerous studies have explored the effect of vitamin K2 MK7 on various cardiovascular markers, including blood pressure. The findings, while not uniformly conclusive across all populations, offer promising insights.

Promising Results in Postmenopausal Women

One landmark three-year, placebo-controlled trial specifically focused on the MenaQ7 brand of vitamin K2 MK7 and its effects on postmenopausal women. The study revealed that daily supplementation with MK7 significantly improved arterial elasticity and reduced arterial stiffness compared to the placebo group. A post-hoc analysis further highlighted that women with a high baseline arterial stiffness saw the most notable improvements, including a significant decrease in blood pressure.

Studies in Kidney Transplant Patients

A pilot study involving renal transplant recipients found that an eight-week regimen of MK7 supplementation was associated with a significant reduction in arterial stiffness and an improvement in both peripheral and central blood pressures. This study suggested that supplementing with MK7 can effectively address subclinical vitamin K deficiency common in this population, leading to tangible vascular health benefits.

Conflicting and Complex Findings

While promising results exist, not all studies have shown a significant effect on blood pressure or calcification progression over shorter durations. Some trials have indicated that the benefits may be more pronounced in specific subgroups or require a longer period of supplementation to become evident. Factors like baseline arterial stiffness, age, and pre-existing health conditions can influence outcomes, indicating that the efficacy of MK7 is complex and not a one-size-fits-all solution.

The Vital Partnership with Vitamin D3

For optimal calcium regulation, vitamin K2 works best in conjunction with vitamin D3. Vitamin D3 enhances the body's absorption of calcium, while vitamin K2 ensures that the absorbed calcium is properly directed to the bones and teeth rather than accumulating in soft tissues like arteries. This synergistic relationship is crucial for both bone and cardiovascular health, explaining why many supplements combine the two vitamins.

Considering Vitamin K2 MK7 Supplementation

Individuals considering vitamin K2 MK7 supplementation should consult with a healthcare provider to determine if it is appropriate for their individual health needs and to discuss any potential interactions with existing medications, particularly blood thinners.

Dietary Sources of Vitamin K2 MK7

While supplements are an option, incorporating foods rich in vitamin K2 MK7 is a natural way to support cardiovascular health. The primary source is natto, a traditional Japanese fermented soybean dish. Other fermented foods and animal products also contain some forms of vitamin K2.

Conclusion: The Evolving Role of Vitamin K2 MK7

While the research on does vitamin K2 MK7 lower blood pressure is still developing, the evidence is compelling. By activating MGP, MK7 effectively prevents vascular calcification and reduces arterial stiffness, two key factors contributing to hypertension. Studies in specific populations, such as postmenopausal women and kidney transplant patients, have shown significant improvements in blood pressure and vascular elasticity. As research continues to unfold, MK7's role in maintaining cardiovascular health is becoming increasingly clear. It is not a cure-all, but a valuable nutritional tool that, when combined with a balanced diet and healthy lifestyle, can contribute to a healthier heart.

Visit the American Heart Association for more information on cardiovascular health.

Frequently Asked Questions

Vitamin K2 MK7 activates Matrix Gla Protein (MGP), a protein synthesized by vascular smooth muscle cells. Activated MGP binds to calcium in the bloodstream, preventing its deposition in the walls of arteries and keeping them flexible.

While generally considered safe for most people, Vitamin K2 can interfere with certain blood-thinning medications like warfarin. If you are taking any prescription medication for blood pressure or other conditions, you must consult your doctor before taking vitamin K2 supplements.

Vitamin K1 (phylloquinone) is found in leafy greens and primarily functions in blood clotting in the liver. Vitamin K2 (menaquinone), especially the MK7 form, has a longer half-life and plays a crucial role in directing calcium to the bones and away from arteries.

The main dietary source of MK7 is natto, a traditional Japanese fermented food, which may not be a regular part of most diets. While some other animal products contain Vitamin K2, supplementation is often recommended to ensure optimal intake for cardiovascular benefits.

The timeline can vary depending on individual factors like initial vitamin K status and baseline arterial health. Some studies, particularly in specific populations like postmenopausal women with high arterial stiffness, have shown significant improvements in vascular markers and blood pressure over one year of supplementation.

If you have high blood pressure, it is essential to consult with a healthcare professional. They can assess your individual situation and determine if Vitamin K2 MK7 supplementation might be a suitable addition to your overall treatment plan.

A deficiency in Vitamin K2 is associated with an increased risk of vascular calcification and arterial stiffness, as the protein MGP is not adequately activated. This can contribute to poorer cardiovascular outcomes.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.